OVERVIEW

Guidelines for the Management of Spontaneous Intracerebral Hemorrhage is organized by American Heart Association (AHA) and will be held from Sep 26, 2016 to Sep 19, 2019.

Target Audience:
Physicians - Stroke Care, Neurology, Emergency Medicine
Nurses, Nurse Practitioners - Stroke Care, Neurology, Emergency Medicine
Other Physician Assistants - Stroke Care, Neurology, Emergency Medicine

Accreditation:
2.00 AMA PRA Category 1 Credits™
2.00 contact hours

Description:
Spontaneous, non-traumatic intracerebral hemorrhage (ICH) remains a significant cause of morbidity and mortality throughout the world. This program is an update to the last ICH Guidelines published in 2010, incorporating the results of new studies published in the interim.

Objectives
• Describe the role that imaging (non-contrast HCT and CTA) play in diagnosing, predicting risk of hematoma expansion and detecting underlying causes of spontaneous intracerebral hemorrhage.
• Evaluate treatment strategies for patients with ICH who are taking a vitamin K antagonist or newer anticoagulation medication (factor Xa inhibitor or direct thrombin agent).
• Recognize that acute lowering of blood pressure in ICH patients with systolic blood pressure between 150-220 mm Hg is safe and may improve functional outcome.
• Develop treatments plans for ICH patients that include initial admission to an area with neuroscience acute care expertise as well as close monitoring for and management of seizures [an alternative one for this could be: Incorporate information from clinical trials and evidence based medicine to guide management (medical and surgical) of patients with intracerebral hemorrhage].
• Describe the roles that blood pressure control, life style modification and anticoagulation decisions play in the prevention of recurrent intracerbral hemorrhage.
• Discuss the importance of a multidisciplinary team in the rehabilitation of patients with intracerebral hemorrhage.